NeuroSense Therapeutics Ltd. (NRSN): 6-K filed Apr 6, 2026

Form type

6-K

Filing date

Apr 6, 2026

Accession number

0001213900-26-040185

Filer

NeuroSense Therapeutics Ltd. (CIK 1875091)